RSV vaccine from GSK shows potential to protect adults 50 to 59

RSV vaccine from GSK shows potential to protect adults 50 to 59

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, … Read more

CDC advisors recommend Pfizer maternal RSV vaccine to protect infants

CDC advisors recommend Pfizer maternal RSV vaccine to protect infants

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice. Swen Pförtner | Picture Alliance | Getty Images The Centers for Disease Control and Prevention’s independent panel of advisors on Friday recommended Pfizer‘s maternal vaccine that protects infants … Read more

FDA approves Pfizer maternal RSV vaccine for infants

FDA approves Pfizer maternal RSV vaccine for infants

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already approved and available in the … Read more

GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine

GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine.  GSK claims Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen used in its own shot. … Read more

GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales

GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will drive future … Read more

CDC recommends Pfizer, GSK RSV vaccines for adults 60 years and older

CDC recommends Pfizer, GSK RSV vaccines for adults 60 years and older

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Vial of respiratory syncytial virus. Manjurul | Istock | Getty Images Centers for Disease Control and Prevention on Thursday recommended that adults 60 years of age and older receive one dose RSV vaccines from Pfizer and GSK after consultation with doctors. Outgoing CDC Director Rochelle Walensky … Read more

Pfizer, GSK RSV vaccines for older adults may prevent thousands of hospitalizations, CDC analysis says

Pfizer, GSK RSV vaccines for older adults may prevent thousands of hospitalizations, CDC analysis says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Vial of respiratory syncytial virus. Manjurul | Istock | Getty Images Vaccinating one million adults aged 65 and over for single shot RSV from Pfizer or GSK it can prevent thousands hospitalization in two seasons of the virus, according to the Centers for Disease Control and … Read more

A CDC advisory committee supports the use of GSK and Pfizer RSV vaccines in adults over 60 years of age

A CDC advisory committee supports the use of GSK and Pfizer RSV vaccines in adults over 60 years of age

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A healthcare worker prepares a flu vaccine before giving it to a local resident in Los Angeles, the United States, on December 17, 2022. Xinhua News Agency | Getty Images An advisory board to the Centers for Disease Control and Prevention on Wednesday recommended that adults … Read more

GSK says the RSV vaccine for older adults provides protection for two seasons

GSK says the RSV vaccine for older adults provides protection for two seasons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A viral vaccine against respiratory syncytial virus is under investigation. Hailshadow | Istock | Getty Images GlaxoSmithKline on Wednesday said that his vaccine for protect adults aged 60 and over from respiratory syncytial virusor RSV, remained effective over two disease seasons. A one dose of injection … Read more

The Pfizer RSV vaccine for older adults is only slightly less effective after 18 months

The Pfizer RSV vaccine for older adults is only slightly less effective after 18 months

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Respiratory syncytial virus – a viral vaccine under investigation Hailshadow | Istock | Getty Images Pfizer‘s the vaccine which protects adults age 60 and older from respiratory syncytial virus it was slightly less effective after 18 months, according to clinical trial results the company announced Wednesday. … Read more

FDA approves Pfizer RSV vaccine for older adults

FDA approves Pfizer RSV vaccine for older adults

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Luis Alvarez | Digital Vision | Getty Images The Food and Drug Administration approved the vaccine it developed on Wednesday Pfizer which protects adults age 60 and older from respiratory syncytial virusa common pathogen that kills and hospitalizes thousands of elderly people each year. Pfizer said … Read more

Here’s what Pfizer and Moderna say is next for their covid vaccines

Here’s what Pfizer and Moderna say is next for their covid vaccines

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist prepares to administer booster shots with the COVID-19 vaccine during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 9, 2022 in Chicago, Illinois. Scott Olson | Getty Images Three years and billions of covid vaccines … Read more

FDA advisors recommend Pfizer’s RSV vaccine for infants, but raise safety concerns

FDA advisors recommend Pfizer’s RSV vaccine for infants, but raise safety concerns

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Respiratory syncytial virus – a viral vaccine under investigation Hailshadow | Istock | Getty Images The Food and Drug Administration’s independent board of advisers on Thursday recommended full approval Pfizer’s vaccine which protects babies from RSV, however, it has raised safety concerns about premature births that … Read more

Pfizer’s RSV infant vaccine has “generally favorable” safety data, FDA staff say

Pfizer’s RSV infant vaccine has “generally favorable” safety data, FDA staff say

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample for respiratory syncytial virus (RSV) test. Jarun011 | Istock | Getty Images US Food and Drug Administration staff said Tuesday Pfizer’s vaccine which protects babies from the respiratory syncytial virus has “generally favorable” security information. FDA staff made the decision in informative documents before … Read more

FDA approves GSK’s RSV vaccine for older adults, world’s first drug against the virus

FDA approves GSK’s RSV vaccine for older adults, world’s first drug against the virus

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Food and Drug Administration on Wednesday approved an RSV the vaccine is produced GlaxoSmithKline for use in adults 60 years of age and older. The approval, the first global regulatory approval for RSV the vaccineis a decisive victory for GSK va race against drug manufacturers … Read more

The FDA says Guillain-Barre syndrome is a possible risk of Pfizer’s RSV vaccine for older adults

The FDA says Guillain-Barre syndrome is a possible risk of Pfizer’s RSV vaccine for older adults

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This 1981 photo provided by the Centers for Disease Control and Prevention (CDC) shows an electron micrograph of respiratory syncytial virus, also known as RSV. CDC via AP The Food and Drug Administration sees a possible risk of Guillain-Barre syndrome in PfizerRSV vaccine for older adults … Read more

A nutritionist shares the best snacks to take on the plane to boost your immune system

A nutritionist shares the best snacks to take on the plane to boost your immune system

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Travelers need to avoid a number of pathogens this winter, including “tripledemic” infections caused by Covid-19, influenza and RSV (respiratory syncytial virus). But there are steps people can take to reduce their chances of getting the disease, say health experts in Spain SHA Wellness Clinic. The … Read more

Why is the flu season so bad this year?

Why is the flu season so bad this year?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE If it seems like everyone around you is getting sick, you’re not imagining it. Flu season has hit the United States unusually early and much harder than usual. “I’m afraid of what’s going to happen this flu season because I don’t think we’ve ever seen a … Read more

The company’s data show that the Pfizer RSV vaccine given to pregnant women is effective in protecting newborns

The company’s data show that the Pfizer RSV vaccine given to pregnant women is effective in protecting newborns

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when mothers are vaccinated late in pregnancy, according to clinical trial data released Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, but can be dangerous for babies … Read more

;
error: Content is protected !!